These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37276358)

  • 21. Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system.
    Bragoszewski P; Turek M; Chacinska A
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28446709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
    Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
    J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin-proteasome system and mitochondria - reciprocity.
    Livnat-Levanon N; Glickman MH
    Biochim Biophys Acta; 2011 Feb; 1809(2):80-7. PubMed ID: 20674813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin-Like Proteasome System Represents a Eukaryotic-Like Pathway for Targeted Proteolysis in Archaea.
    Fu X; Liu R; Sanchez I; Silva-Sanchez C; Hepowit NL; Cao S; Chen S; Maupin-Furlow J
    mBio; 2016 May; 7(3):. PubMed ID: 27190215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteins containing ubiquitin-like (Ubl) domains not only bind to 26S proteasomes but also induce their activation.
    Collins GA; Goldberg AL
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4664-4674. PubMed ID: 32071216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
    Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
    J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CLPP deficiency ameliorates neurodegeneration caused by impaired mitochondrial protein synthesis.
    Rumyantseva A; Popovic M; Trifunovic A
    Brain; 2022 Mar; 145(1):92-104. PubMed ID: 35240691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ubiquitin-proteasome system and its crosstalk with mitochondria as therapeutic targets in medicine.
    Kodroń A; Mussulini BH; Pilecka I; Chacińska A
    Pharmacol Res; 2021 Jan; 163():105248. PubMed ID: 33065283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitination of specific mitochondrial matrix proteins.
    Lehmann G; Ziv T; Braten O; Admon A; Udasin RG; Ciechanover A
    Biochem Biophys Res Commun; 2016 Jun; 475(1):13-8. PubMed ID: 27157140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-Dependent Degradation of Mitochondrial Proteins Regulates Energy Metabolism.
    Lavie J; De Belvalet H; Sonon S; Ion AM; Dumon E; Melser S; Lacombe D; Dupuy JW; Lalou C; Bénard G
    Cell Rep; 2018 Jun; 23(10):2852-2863. PubMed ID: 29874573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic proteasomes are not indispensable for cell growth in Saccharomyces cerevisiae.
    Tsuchiya H; Arai N; Tanaka K; Saeki Y
    Biochem Biophys Res Commun; 2013 Jul; 436(3):372-6. PubMed ID: 23747422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologics-based degraders - an expanding toolkit for targeted-protein degradation.
    VanDyke D; Taylor JD; Kaeo KJ; Hunt J; Spangler JB
    Curr Opin Biotechnol; 2022 Dec; 78():102807. PubMed ID: 36179405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment.
    Daglish SCD; Fennell EMJ; Graves LM
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early degradation of paternal mitochondria in domestic pig (Sus scrofa) is prevented by selective proteasomal inhibitors lactacystin and MG132.
    Sutovsky P; McCauley TC; Sutovsky M; Day BN
    Biol Reprod; 2003 May; 68(5):1793-800. PubMed ID: 12606393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the Overall Rate of Protein Breakdown in Cells and the Contributions of the Ubiquitin-Proteasome and Autophagy-Lysosomal Pathways.
    Sha Z; Zhao J; Goldberg AL
    Methods Mol Biol; 2018; 1844():261-276. PubMed ID: 30242715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras.
    Darwish S; Heimburg T; Ridinger J; Herp D; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
    Methods Mol Biol; 2023; 2589():179-193. PubMed ID: 36255625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.
    Luh LM; Scheib U; Juenemann K; Wortmann L; Brands M; Cromm PM
    Angew Chem Int Ed Engl; 2020 Sep; 59(36):15448-15466. PubMed ID: 32428344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.